## Core Concept
The question tests the understanding of the physiological response to hemorrhage, specifically focusing on the role of blood platelets in vasoconstriction. During hemorrhage, the body attempts to minimize blood loss through vasoconstriction and coagulation. Platelets play a crucial role in this process.

## Why the Correct Answer is Right
Thromboxane A2 is a powerful vasoconstrictor and is released by platelets during hemorrhage. It acts on vascular smooth muscle to cause vasoconstriction, which helps in reducing blood flow to the injured area and subsequently reduces bleeding. Thromboxane A2 also promotes platelet aggregation, which is essential for the formation of a blood clot.

## Why Each Wrong Option is Incorrect
* **Option A:** Prostaglandin E2 (PGE2) is primarily involved in inflammation and has vasodilatory properties, which is the opposite of what is required during hemorrhage to reduce bleeding.
* **Option B:** Prostaglandin I2 (PGI2), also known as prostacyclin, is a potent vasodilator and inhibits platelet aggregation. Its effects are contrary to the vasoconstriction and platelet aggregation needed during hemorrhage.
* **Option D:** Leukotriene D4 (LTD4) is involved in inflammatory responses and causes vasoconstriction but is not primarily released by platelets during hemorrhage for the purpose of vasoconstriction.

## Clinical Pearl / High-Yield Fact
A key point to remember is that thromboxane A2, produced by platelets, is a critical component in the process of hemostasis. It not only causes vasoconstriction but also promotes platelet aggregation, making it a vital factor in the body's response to injury and hemorrhage.

## Correct Answer: C. Thromboxane A2.